Table 7 Knowledge of HBV care and treatment among healthcare workers participating in the quantitative component of the survey (n = 87)
Variables (% of missing data) | Total | HCW mainly involved in prenatal care activities (Group 1) | HCW involved exclusively in vaccination activities (Group 2) | p-valuea |
|---|---|---|---|---|
(N = 87) | (N = 47, 54%) | (N = 40, 46%) | ||
N (%) | ||||
Is there an effective treatment against chronic hepatitis B infection? (2%) | ||||
Correct answer | 38 (45) | 17 (37) | 21 (54) | 0.12 |
Incorrect answer | 47(55) | 29 (63) | 18 (46) | |
How long does antiviral therapy against chronic hepatitis B continue? (1%) | ||||
Correct answer | 33 (38) | 21 (46) | 12 (30) | 0.12 |
Incorrect answer | 55 (62) | 25 (54) | 28 (70) | |
Which of the following treatments has proven efficacy against chronic hepatitis B infection? | ||||
Lamiduvine (3%) | ||||
Correct answer | 6 (7) | 4 (9) | 2 (5) | 0.41 |
Incorrect answer | 78 (93) | 41 (91) | 37 (95) | |
Tenofovir (5%) | ||||
Correct answer | 8 (10) | 5 (11) | 3 (8) | 0.43 |
Incorrect answer | 75 (90) | 39 (89) | 36 (92) | |
What are the potential strategies for reducing perinatal transmission? | ||||
Antiviral treatment for the mother (1%) | ||||
Correct answer | 47 (55) | 28 (60) | 19 (49) | 0.21 |
Incorrect answer | 39 (45) | 19 (40) | 20 (51) | |
Immune globulin administration (2%) | ||||
Correct answer | 20 (23) | 10 (21) | 10 (26) | 0.79 |
Incorrect answer | 65 (77) | 37 (79) | 28 (74) | |